Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Risk Factors [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
apnea, obstructive sleep [NCBI] 0.00580675
APOE [NCBI] 0.00405196
CRC [NCBI] 0.00264968
VRNI [NCBI] 0.00261862
AD [NCBI] 0.00211908
MDD [NCBI] 0.0016449
lymphoma, non-hodgkin, familial [NCBI] 0.00159878
abdominal obesity-metabolic syndrome [NCBI] 0.00153019
KLK3 [NCBI] 0.0012408
testicular germ cell tumor 1 [NCBI] 0.0012054
BULN1 [NCBI] 0.00117533
SLE [NCBI] 0.0011005
aneurysm, intracranial berry, 1 [NCBI] 0.00103878
HPC10 [NCBI] 0.00103828
PEE1 [NCBI] 0.00098126
cluster headache, familial [NCBI] 0.000927717
CHDS8 [NCBI] 0.00084843
cataract, age-related cortical [NCBI] 0.00084843
autism [NCBI] 0.00071843
ATHS [NCBI] 0.000705268
restless legs syndrome, susceptibility to, 6 [NCBI] 0.00069167
CELIAC6 [NCBI] 0.00069167
coronary heart disease, susceptibility to, 1 [NCBI] 0.000602417
HSCR7 [NCBI] 0.000602417
gallbladder disease 2 [NCBI] 0.000602417
major depressive disorder 2 [NCBI] 0.000602417
mammographic density [NCBI] 0.000602417
gallbladder disease 3 [NCBI] 0.000602417
HSCR6 [NCBI] 0.000602417
high density lipoprotein cholesterol level quantitative trait locus 3 [NCBI] 0.000602417
LOH18CR1 [NCBI] 0.000602417
exstrophy of bladder [NCBI] 0.000602417
MRX42 [NCBI] 0.000602417
peripheral arterial occlusive disease 1 [NCBI] 0.000602417
BMND7 [NCBI] 0.000602417
coronary heart disease, susceptibility to, 4 [NCBI] 0.000602417
HDLCQ1 [NCBI] 0.000602417
MAFD6 [NCBI] 0.000586495
EGF [NCBI] 0.000543837
homocysteinemia [NCBI] 0.00053509
migraine with or without aura, susceptibility to, 1 [NCBI] 0.000484757
amyloidosis vi [NCBI] 0.000480333
APOB [NCBI] 0.000479246
ACE [NCBI] 0.000475093
APC [NCBI] 0.000474074
mental health wellness 1 [NCBI] 0.000445969
SHBG [NCBI] 0.000435208
MAFD1 [NCBI] 0.000429856
CFH [NCBI] 0.000429096
AFP [NCBI] 0.000408431
CJD [NCBI] 0.000400275
ANON1 [NCBI] 0.000394867
pulmonary disease, chronic obstructive [NCBI] 0.000394867
alzheimer disease 5 [NCBI] 0.000394867
ARMD4 [NCBI] 0.000384452
VDR [NCBI] 0.000366091
acne inversa, familial [NCBI] 0.000345577
brachial palsy, familial congenital [NCBI] 0.000345577
panic disorder 3 [NCBI] 0.000345577
FTSD [NCBI] 0.000345577
alzheimer disease 7 [NCBI] 0.000345577
neural tube defects, folate-sensitive [NCBI] 0.000334479
NGFB [NCBI] 0.000322356
MTHFR [NCBI] 0.000320063
temporal arteritis [NCBI] 0.000307433
PD [NCBI] 0.00030486
RP [NCBI] 0.000290456
ARMD1 [NCBI] 0.00027775
PCOS1 [NCBI] 0.000262879
COMT [NCBI] 0.000260858
pelvic organ prolapse [NCBI] 0.00025385
hypoadrenocorticism, familial [NCBI] 0.00025385
acanthosis nigricans [NCBI] 0.00025385
ATFB1 [NCBI] 0.00025385
myopia 6 [NCBI] 0.00025385
restless legs syndrome, susceptibility to, 3 [NCBI] 0.00025385
testicular microlithiasis [NCBI] 0.00025385
CPI [NCBI] 0.000250869
carotid intimal medial thickness 1 [NCBI] 0.000250049
MG [NCBI] 0.000240785
LPL [NCBI] 0.000238927
FEB1 [NCBI] 0.000229569
aortic aneurysm, abdominal [NCBI] 0.000223926
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity [NCBI] 0.000211803
HFM [NCBI] 0.000208336
MBL2 [NCBI] 0.000205692
peyronie disease [NCBI] 0.000197221
endometriosis, susceptibility to, 1 [NCBI] 0.000197221
sneddon syndrome [NCBI] 0.000197221
kala-azar, susceptibility to, 1 [NCBI] 0.000197221
pulmonary function [NCBI] 0.000197221
parkinson disease 12 [NCBI] 0.000197221
sclerotylosis [NCBI] 0.000197221
OB10P [NCBI] 0.000197221
CARASIL [NCBI] 0.000197221
BRCA3 [NCBI] 0.000197221
nasopharyngeal carcinoma 1 [NCBI] 0.000197221
RA [NCBI] 0.000196069
aspirin resistance [NCBI] 0.000192325
factor v deficiency [NCBI] 0.000189985
stroke, ischemic [NCBI] 0.000189965
PAND1 [NCBI] 0.000187198
FA [NCBI] 0.000187168
CPB2 [NCBI] 0.00017872
VIP [NCBI] 0.000176296
ACHE [NCBI] 0.000175979
CF [NCBI] 0.000164347
gastric cancer [NCBI] 0.000161351
spinal muscular atrophy, childhood, proximal, autosomal dominant [NCBI] 0.000157262
cerebral palsy, ataxic, autosomal recessive [NCBI] 0.000157262
leptin, serum levels of [NCBI] 0.000157262
CMD1B [NCBI] 0.000157262
breast cancer [NCBI] 0.000151915
RTT [NCBI] 0.000150992
BRCA1 [NCBI] 0.00014621
PON1 [NCBI] 0.000145814
bilirubin, elevated concentrations of, in serum [NCBI] 0.000143368
IDDM [NCBI] 0.000142516
MTR [NCBI] 0.00014075
NAT1 [NCBI] 0.000134431
CRP [NCBI] 0.000132527
PAI1 [NCBI] 0.000128557
TH [NCBI] 0.000127648
OFD4 [NCBI] 0.000127121
schinzel-giedion midface-retraction syndrome [NCBI] 0.000127121
CNC2 [NCBI] 0.000127121
CCK [NCBI] 0.000126887
NPY [NCBI] 0.000126621
SCZD3 [NCBI] 0.000124381
CD [NCBI] 0.000124268
CVID [NCBI] 0.000119368
CCND1 [NCBI] 0.000118896
AVP [NCBI] 0.000117432
CMM [NCBI] 0.000114909
PRL [NCBI] 0.000113942
PTH [NCBI] 0.000112672
PWS [NCBI] 0.000109676
behcet syndrome [NCBI] 0.000108789
PPR [NCBI] 0.000108789
GFAP [NCBI] 0.000108134
OFC1 [NCBI] 0.000108102
thrombophilia [NCBI] 0.000106919
AS [NCBI] 0.000106881
MBP [NCBI] 0.000105953
APS2 [NCBI] 0.000103469
hodgkin disease, x-linked pseudoautosomal [NCBI] 0.000103469
neuropathy, hereditary motor and sensory, russe type [NCBI] 0.000103469
renal cell carcinoma, papillary, 3 [NCBI] 0.000103469
QPD [NCBI] 0.000103469
MNG1 [NCBI] 0.000103469
F2 [NCBI] 0.000100796
prostate cancer [NCBI] 0.000100669
CHAT [NCBI] 9.86824e-05
WAS [NCBI] 9.85338e-05
XFS [NCBI] 9.74254e-05
ESR1 [NCBI] 9.6704e-05
DGS [NCBI] 9.5904e-05
MODY [NCBI] 9.14001e-05
HD [NCBI] 9.11645e-05
PPROM [NCBI] 8.76602e-05
sudden infant death syndrome [NCBI] 8.75797e-05
SLOS [NCBI] 8.72388e-05
neuroticism [NCBI] 8.44284e-05
gastroesophageal reflux [NCBI] 8.44284e-05
CTS1 [NCBI] 8.44284e-05
alzheimer disease 8 [NCBI] 8.44284e-05
prostate cancer, hereditary, 8 [NCBI] 8.44284e-05
alcohol dependence [NCBI] 8.36899e-05
aortic valve disease [NCBI] 8.23037e-05
UBQLN1 [NCBI] 8.03549e-05
BL [NCBI] 7.99827e-05
MS [NCBI] 7.80211e-05
MC1R [NCBI] 7.80137e-05
TFPI [NCBI] 7.7287e-05
FTD [NCBI] 7.70184e-05
DRPLA [NCBI] 7.63475e-05
BRCA2 [NCBI] 7.59441e-05
MJD [NCBI] 7.45504e-05
danubian endemic familial nephropathy [NCBI] 7.30473e-05
sickle cell anemia [NCBI] 7.29856e-05
LTA [NCBI] 7.29787e-05
CRH [NCBI] 7.25966e-05
HLA-DRB1 [NCBI] 7.19875e-05
TSD [NCBI] 7.08977e-05
SCZD7 [NCBI] 6.88363e-05
SCZD6 [NCBI] 6.88363e-05
SMAX1 [NCBI] 6.8677e-05
MFS [NCBI] 6.81322e-05
brugada syndrome 1 [NCBI] 6.77045e-05
ALD [NCBI] 6.71565e-05
ADIPOQ [NCBI] 6.6938e-05
panencephalitis, subacute sclerosing [NCBI] 6.54712e-05
PAPPA [NCBI] 6.42578e-05
TCF7L2 [NCBI] 6.34182e-05
DMD [NCBI] 6.33643e-05
dystrophia myotonica 1 [NCBI] 6.30863e-05
folate level in erythrocytes [NCBI] 6.25033e-05
BPH [NCBI] 6.25033e-05
coronary heart disease, susceptibility to, 7 [NCBI] 6.25033e-05
pancreatitis, sclerosing cholangitis, and sicca complex [NCBI] 6.25033e-05
ADCAD2 [NCBI] 6.25033e-05
cardiac septal defects with coarctation of the aorta [NCBI] 6.25033e-05
fitzsimmons-guilbert syndrome [NCBI] 6.25033e-05
HPS [NCBI] 6.18636e-05
BDNF [NCBI] 6.14588e-05
sarcoidosis [NCBI] 6.04732e-05
optic nerve hypoplasia, bilateral [NCBI] 6.03087e-05
respiratory distress syndrome in premature infants [NCBI] 6.03087e-05
restless legs syndrome, susceptibility to, 1 [NCBI] 5.72109e-05
myeloproliferative syndrome, transient [NCBI] 5.72109e-05
SHH [NCBI] 5.66101e-05
WM1 [NCBI] 5.59212e-05
SCZD [NCBI] 5.40817e-05
PG [NCBI] 5.37064e-05
fragile x mental retardation syndrome [NCBI] 5.26984e-05
BBS [NCBI] 5.21991e-05
KSS [NCBI] 5.21991e-05
SOD2 [NCBI] 5.21259e-05
nonarteritic anterior ischemic optic neuropathy, susceptibility to [NCBI] 5.21171e-05
PMF [NCBI] 5.21171e-05
gastroschisis [NCBI] 5.21171e-05
nasopharyngeal carcinoma [NCBI] 5.21171e-05
kaposi sarcoma [NCBI] 5.17419e-05
osteoporosis [NCBI] 5.14888e-05
DTNBP1 [NCBI] 5.00566e-05
TS [NCBI] 4.91659e-05
NPPA [NCBI] 4.84867e-05
LFS1 [NCBI] 4.79317e-05
HGF [NCBI] 4.60582e-05
cerebral palsy, spastic, symmetric, autosomal recessive [NCBI] 4.56329e-05
hypospadias, autosomal [NCBI] 4.56329e-05
mental health wellness 2 [NCBI] 4.56329e-05
OTSC1 [NCBI] 4.51449e-05
IBD5 [NCBI] 4.51449e-05
AGT [NCBI] 4.51117e-05
IP [NCBI] 4.4934e-05
DLB [NCBI] 4.45929e-05
PROCR [NCBI] 4.45112e-05
diabetes mellitus, insulin-dependent, 2 [NCBI] 4.45075e-05
EGFR [NCBI] 4.35677e-05
GDNF [NCBI] 4.34962e-05
hypercholesterolemia, autosomal dominant [NCBI] 4.27878e-05
POAG [NCBI] 4.22782e-05
HLA-G [NCBI] 4.20083e-05
HPC1 [NCBI] 4.14755e-05
CHEK2 [NCBI] 4.1428e-05
PJS [NCBI] 4.07521e-05
NOS3 [NCBI] 4.06401e-05
IDD [NCBI] 4.0311e-05
AHR [NCBI] 3.96262e-05
OPMD [NCBI] 3.9249e-05
MMP3 [NCBI] 3.87299e-05
SRD5A2 [NCBI] 3.79783e-05
TNFRSF11B [NCBI] 3.74494e-05
PTHLH [NCBI] 3.70886e-05
IL6 [NCBI] 3.69331e-05
HBB [NCBI] 3.66714e-05
PMD [NCBI] 3.62848e-05
telomere length, mean leukocyte [NCBI] 3.61169e-05
iron overload in africa [NCBI] 3.58329e-05
hypoalphalipoproteinemia, primary [NCBI] 3.58329e-05
acne, adult [NCBI] 3.56343e-05
ARMD9 [NCBI] 3.56343e-05
periodontitis, chronic [NCBI] 3.56343e-05
brain small vessel disease with hemorrhage [NCBI] 3.56343e-05
orofacial cleft 6 [NCBI] 3.56343e-05
HPE7 [NCBI] 3.56343e-05
HMN7B [NCBI] 3.56343e-05
ADA [NCBI] 3.53237e-05
BTBD9 [NCBI] 3.49731e-05
CYP46A1 [NCBI] 3.49731e-05
ITGA2 [NCBI] 3.45705e-05
HCRTR2 [NCBI] 3.45705e-05
MSR1 [NCBI] 3.45705e-05
OLR1 [NCBI] 3.45705e-05
MTHFD1 [NCBI] 3.45705e-05
TNFSF6 [NCBI] 3.45222e-05
GSTP1 [NCBI] 3.38672e-05
FOLR1 [NCBI] 3.3271e-05
WBS [NCBI] 3.2714e-05
INS [NCBI] 3.21333e-05
FMF [NCBI] 3.20488e-05
GBD1 [NCBI] 3.1996e-05
HLA-B [NCBI] 3.17619e-05
HP [NCBI] 3.15537e-05
POMC [NCBI] 3.02084e-05
EPHX1 [NCBI] 2.98675e-05
BCNS [NCBI] 2.97754e-05
ACP5 [NCBI] 2.974e-05
TTR [NCBI] 2.96889e-05
LAM [NCBI] 2.9199e-05
PCD [NCBI] 2.9199e-05
DLG5 [NCBI] 2.89076e-05
CADASIL [NCBI] 2.8882e-05
wagr syndrome [NCBI] 2.86632e-05
ST8 [NCBI] 2.85449e-05
DHFR [NCBI] 2.82298e-05
IS1 [NCBI] 2.81878e-05
PTPN22 [NCBI] 2.80314e-05
MUC1 [NCBI] 2.77012e-05
CAT [NCBI] 2.76747e-05
NOD2 [NCBI] 2.76107e-05
PCNA [NCBI] 2.72207e-05
NNMT [NCBI] 2.71701e-05
PYY [NCBI] 2.6862e-05
HLA-DPB1 [NCBI] 2.67937e-05
XDH [NCBI] 2.6665e-05
PSEN1 [NCBI] 2.63344e-05
WRN [NCBI] 2.6328e-05
arcus corneae [NCBI] 2.60561e-05
DTGA1 [NCBI] 2.60561e-05
FEB8 [NCBI] 2.60561e-05
cataract, age-related nuclear [NCBI] 2.60561e-05
stroke, susceptibility to, 1 [NCBI] 2.60561e-05
tracheoesophageal fistula with or without esophageal atresia [NCBI] 2.60561e-05
pseudopapilledema [NCBI] 2.60561e-05
FEB3 [NCBI] 2.60561e-05
ADCAD1 [NCBI] 2.60561e-05
basal cell carcinoma, multiple [NCBI] 2.60561e-05
leprosy, susceptibility to, 4 [NCBI] 2.60561e-05
diabetic nephropathy, susceptibility to [NCBI] 2.60561e-05
plasminogen deficiency, type i [NCBI] 2.57373e-05
BLM [NCBI] 2.56757e-05
LS [NCBI] 2.56757e-05
ATP13A4 [NCBI] 2.5653e-05
flj10986 [NCBI] 2.5653e-05
MIAT [NCBI] 2.5653e-05
LPA [NCBI] 2.56063e-05
GH1 [NCBI] 2.56041e-05
GAPDH [NCBI] 2.50967e-05
CAPN10 [NCBI] 2.48524e-05
VLDLR [NCBI] 2.4241e-05
CDSN [NCBI] 2.41554e-05
MYOC [NCBI] 2.37497e-05
FGF20 [NCBI] 2.35068e-05
MTRR [NCBI] 2.35068e-05
HCF2 [NCBI] 2.35068e-05
alzheimer disease 2 [NCBI] 2.31467e-05
septooptic dysplasia [NCBI] 2.31467e-05
AR [NCBI] 2.30724e-05
IBD1 [NCBI] 2.27386e-05
CCD [NCBI] 2.2465e-05
HFE [NCBI] 2.23477e-05
GSTM1 [NCBI] 2.22492e-05
leber optic atrophy, susceptibility to [NCBI] 2.22044e-05
CYP2E [NCBI] 2.2179e-05
urogenital adysplasia, hereditary [NCBI] 2.2076e-05
osteoarthritis [NCBI] 2.20426e-05
MPO [NCBI] 2.19999e-05
FGF7 [NCBI] 2.17542e-05
SLC6A3 [NCBI] 2.14982e-05
ATM [NCBI] 2.06985e-05
DISC1 [NCBI] 2.0574e-05
UCP2 [NCBI] 2.04824e-05
asthma-related traits, susceptibility to, 2 [NCBI] 2.01532e-05
brachydactyly-ectrodactyly with fibular aplasia or hypoplasia [NCBI] 2.01532e-05
FIDD [NCBI] 2.01532e-05
ARMD2 [NCBI] 2.01532e-05
pelizaeus-merzbacher-like disease, autosomal recessive, 1 [NCBI] 2.01532e-05
CELIAC4 [NCBI] 2.01532e-05
CMT4H [NCBI] 2.01532e-05
polydactyly, preaxial i [NCBI] 2.01532e-05
pars planitis [NCBI] 2.01532e-05
PRODH [NCBI] 2.00588e-05
PSEN2 [NCBI] 2.00186e-05
loc387715 gene [NCBI] 1.99437e-05
CX3CR1 [NCBI] 1.99437e-05
IRF5 [NCBI] 1.99437e-05
PLTP [NCBI] 1.97484e-05
IL1A [NCBI] 1.95628e-05
IL18 [NCBI] 1.95628e-05
CETP [NCBI] 1.95628e-05
MAFD2 [NCBI] 1.91272e-05
CDH1 [NCBI] 1.90382e-05
ALB [NCBI] 1.87875e-05
esophageal cancer [NCBI] 1.87671e-05
CMTC [NCBI] 1.87671e-05
GIST [NCBI] 1.86566e-05
homocystinuria [NCBI] 1.84882e-05
ITGB3 [NCBI] 1.84181e-05
cortisol 11-beta-ketoreductase deficiency [NCBI] 1.84181e-05
EIG [NCBI] 1.83306e-05
CYP19A1 [NCBI] 1.81174e-05
HLA-C [NCBI] 1.81119e-05
BLMH [NCBI] 1.81119e-05
DRD1 [NCBI] 1.81119e-05
testicular tumors [NCBI] 1.78059e-05
CYP2A6 [NCBI] 1.77487e-05
IQCJ [NCBI] 1.74857e-05
TMPRSS11A [NCBI] 1.74857e-05
KIAA1109 [NCBI] 1.74857e-05
UQCRC2 [NCBI] 1.74857e-05
CD14 [NCBI] 1.73087e-05
PLA2G7 [NCBI] 1.73087e-05
HABP2 [NCBI] 1.73087e-05
GAL [NCBI] 1.6987e-05
glaucoma-related pigment dispersion syndrome [NCBI] 1.69191e-05
alopecia areata 1 [NCBI] 1.69191e-05
helicobacter pylori infection, susceptibility to [NCBI] 1.6903e-05
protein c deficiency, congenital thrombotic disease due to [NCBI] 1.67006e-05
PDCD1 [NCBI] 1.65668e-05
ALOX5AP [NCBI] 1.65668e-05
MICA [NCBI] 1.65408e-05
OPTN [NCBI] 1.65408e-05
ADRB2 [NCBI] 1.65408e-05
ND [NCBI] 1.63374e-05
velocardiofacial syndrome [NCBI] 1.63374e-05
TF [NCBI] 1.62088e-05
CCR5 [NCBI] 1.61711e-05
PDYN [NCBI] 1.61631e-05
thrombophilia due to deficiency of activated protein c cofactor [NCBI] 1.5996e-05
west nile virus, susceptibility to [NCBI] 1.5996e-05
retinitis pigmentosa, x-linked, with recurrent respiratory infections [NCBI] 1.5996e-05
recombinant chromosome 8 syndrome [NCBI] 1.5996e-05
budd-chiari syndrome [NCBI] 1.5996e-05
IL10 [NCBI] 1.59137e-05
ELAC2 [NCBI] 1.5878e-05
PLIN [NCBI] 1.5878e-05
GHRH [NCBI] 1.587e-05
DBA [NCBI] 1.58233e-05
MEN2A [NCBI] 1.57498e-05
ornithine transcarbamylase deficiency, hyperammonemia due to [NCBI] 1.57498e-05
TP53 [NCBI] 1.56976e-05
AGER [NCBI] 1.5619e-05
NRG1 [NCBI] 1.53084e-05
FGB [NCBI] 1.52361e-05
GJA4 [NCBI] 1.52361e-05
LRRK2 [NCBI] 1.51693e-05
TD1 [NCBI] 1.51672e-05
BHMT [NCBI] 1.46355e-05
TLR4 [NCBI] 1.44707e-05
ATP5C1 [NCBI] 1.4453e-05
ARL11 [NCBI] 1.4453e-05
LZTS1 [NCBI] 1.4453e-05
CYP4B1 [NCBI] 1.4453e-05
GIP [NCBI] 1.43766e-05
human immunodeficiency virus type 1, susceptibility to [NCBI] 1.42912e-05
ADRB3 [NCBI] 1.40718e-05
LEP [NCBI] 1.39252e-05
factor xii deficiency [NCBI] 1.36908e-05
bladder cancer [NCBI] 1.36908e-05
SHEP2 [NCBI] 1.36908e-05
PHOX2B [NCBI] 1.35412e-05
HSD11B1 [NCBI] 1.35412e-05
GNRH1 [NCBI] 1.34225e-05
FRAP1 [NCBI] 1.32195e-05
ectopia lentis, isolated [NCBI] 1.28669e-05
glaucoma, normal tension, susceptibility to [NCBI] 1.28669e-05
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked [NCBI] 1.28669e-05
HOA [NCBI] 1.28669e-05
elejalde disease [NCBI] 1.28669e-05
DFNA11 [NCBI] 1.28669e-05
oeis complex [NCBI] 1.28669e-05
CFTR [NCBI] 1.26994e-05
fabry disease [NCBI] 1.25166e-05
SMYD3 [NCBI] 1.25117e-05
PRKCH [NCBI] 1.25117e-05
TSNAX [NCBI] 1.25117e-05
CFHR3 [NCBI] 1.25117e-05
CH25H [NCBI] 1.25117e-05
PSMA6 [NCBI] 1.25117e-05
GAPDHS [NCBI] 1.25117e-05
isoniazid inactivation [NCBI] 1.23898e-05
MKS1 [NCBI] 1.2338e-05
PCLD [NCBI] 1.23028e-05
F3 [NCBI] 1.22339e-05
SCN5A [NCBI] 1.21267e-05
AACT [NCBI] 1.21179e-05
CASP8 [NCBI] 1.21179e-05
MTND3 [NCBI] 1.16914e-05
AVSD [NCBI] 1.16839e-05
MYH7 [NCBI] 1.13754e-05
drug metabolism, poor, cyp2d6-related [NCBI] 1.13623e-05
A2M [NCBI] 1.11369e-05
CCL24 [NCBI] 1.10887e-05
GPR44 [NCBI] 1.10887e-05
ZDHHC8 [NCBI] 1.10887e-05
SLC34A2 [NCBI] 1.10887e-05
SH3TC2 [NCBI] 1.10887e-05
CSTA [NCBI] 1.10887e-05
ESX1L [NCBI] 1.10887e-05
RAD54L [NCBI] 1.10887e-05
KIR2DS2 [NCBI] 1.10887e-05
IFNA2 [NCBI] 1.10887e-05
saitohin [NCBI] 1.10887e-05
FADS1 [NCBI] 1.10887e-05
LRP1 [NCBI] 1.10887e-05
PLCB1 [NCBI] 1.10887e-05
GCK [NCBI] 1.10802e-05
HTR2A [NCBI] 1.08991e-05
TNF [NCBI] 1.08171e-05
ABCC1 [NCBI] 1.0558e-05
ADH2 [NCBI] 1.05301e-05
AN1 [NCBI] 1.04171e-05
pancreatic cancer, susceptibility to, 1 [NCBI] 1.04171e-05
avascular necrosis of femoral head, primary [NCBI] 1.04171e-05
asthma, nasal polyps, and aspirin intolerance [NCBI] 1.04171e-05
CPVT [NCBI] 1.04171e-05
three m syndrome [NCBI] 1.04171e-05
megalencephaly-cutis marmorata telangiectatica congenita [NCBI] 1.04171e-05
aplastic anemia [NCBI] 1.04171e-05
pemphigus vulgaris, familial [NCBI] 1.04171e-05
MAS [NCBI] 1.0305e-05
LCAT [NCBI] 1.02655e-05
RCC1 [NCBI] 1.01868e-05
BTNL2 [NCBI] 9.97107e-06
VANGL1 [NCBI] 9.97107e-06
SEPS1 [NCBI] 9.97107e-06
CHRNB4 [NCBI] 9.97107e-06
ADRA2C [NCBI] 9.97107e-06
CD24 [NCBI] 9.97107e-06
GJC2 [NCBI] 9.97107e-06
MTF1 [NCBI] 9.97107e-06
IMPA2 [NCBI] 9.97107e-06
MLX [NCBI] 9.97107e-06
FABP2 [NCBI] 9.84001e-06
GP1BA [NCBI] 9.51676e-06
PTX3 [NCBI] 9.51676e-06
NR1I2 [NCBI] 9.4422e-06
IRS1 [NCBI] 9.41503e-06
SDS [NCBI] 9.36169e-06
IL1B [NCBI] 9.20674e-06
CD40LG [NCBI] 9.20674e-06
CST3 [NCBI] 9.20674e-06
MMP8 [NCBI] 9.05517e-06
PTPRZ1 [NCBI] 9.05517e-06
PTPRN [NCBI] 9.05517e-06
ACH [NCBI] 8.95556e-06
MTRNR1 [NCBI] 8.90913e-06
ulcerative colitis, susceptibility to [NCBI] 8.83518e-06
AMC [NCBI] 8.64907e-06
AN2 [NCBI] 8.64907e-06
PGR [NCBI] 8.64284e-06
JMML [NCBI] 8.63751e-06
CXCL12 [NCBI] 8.62315e-06
CCL2 [NCBI] 8.4836e-06
rheumatoid arthritis, systemic juvenile [NCBI] 8.45013e-06
GS1 [NCBI] 8.45013e-06
TRS [NCBI] 8.45013e-06
vitiligo [NCBI] 8.45013e-06
SCA8 [NCBI] 8.45013e-06
CMT4B1 [NCBI] 8.45013e-06
deafness, autosomal recessive [NCBI] 8.45013e-06
hyperbilirubinemia, transient familial neonatal [NCBI] 8.45013e-06
PCI [NCBI] 8.3549e-06
EV [NCBI] 8.35173e-06
SAA1 [NCBI] 8.34812e-06
CDK2 [NCBI] 8.31287e-06
GPR154 [NCBI] 8.28264e-06
SRD5A1 [NCBI] 8.28264e-06
RPL7A [NCBI] 8.28264e-06
COL9A3 [NCBI] 8.28264e-06
HSD17B1 [NCBI] 8.28264e-06
TAS2R16 [NCBI] 8.28264e-06
KCNJ8 [NCBI] 8.28264e-06
SLC22A4 [NCBI] 8.28264e-06
PDCD8 [NCBI] 8.25419e-06
CTGF [NCBI] 8.23436e-06
HNPP [NCBI] 8.15247e-06
GRA [NCBI] 8.15247e-06
FFI [NCBI] 8.04794e-06
DRD4 [NCBI] 7.97005e-06
PRNP [NCBI] 7.76268e-06
FGFR3 [NCBI] 7.72974e-06
galactosemia [NCBI] 7.66439e-06
hypertrophic neuropathy of dejerine-sottas [NCBI] 7.66439e-06
GCKR [NCBI] 7.61732e-06
GAB2 [NCBI] 7.61732e-06
GCLM [NCBI] 7.61732e-06
GZMK [NCBI] 7.61732e-06
EDNRA [NCBI] 7.61732e-06
CFHR1 [NCBI] 7.61732e-06
HTR2C [NCBI] 7.61732e-06
SEMA5A [NCBI] 7.61732e-06
ADRA1B [NCBI] 7.61732e-06
ABCA2 [NCBI] 7.61732e-06
MYLK [NCBI] 7.61732e-06
F2RL3 [NCBI] 7.61732e-06
LMO4 [NCBI] 7.61732e-06
FCAR [NCBI] 7.61732e-06
IRF2 [NCBI] 7.61732e-06
PPARG [NCBI] 7.59447e-06
ABCC6 [NCBI] 7.58258e-06
SERPINA6 [NCBI] 7.55644e-06
ALDH2 [NCBI] 7.34548e-06
CYP3A4 [NCBI] 7.34548e-06
osteogenesis imperfecta, type iia [NCBI] 7.18521e-06
neuroblastoma [NCBI] 7.18521e-06
SMARCA3 [NCBI] 7.03521e-06
APOA5 [NCBI] 7.03521e-06
EPHX2 [NCBI] 7.03521e-06
HAS1 [NCBI] 7.03521e-06
ASPN [NCBI] 7.03521e-06
TNNI2 [NCBI] 7.03521e-06
CRMO [NCBI] 6.99724e-06
HNMT [NCBI] 6.89559e-06
osteogenic sarcoma [NCBI] 6.84421e-06
tobacco addiction, susceptibility to [NCBI] 6.84421e-06
renal cell carcinoma, papillary [NCBI] 6.84421e-06
GGM [NCBI] 6.84421e-06
polydactyly, postaxial, type a1 [NCBI] 6.84421e-06
complement factor i deficiency [NCBI] 6.84421e-06
GS2 [NCBI] 6.84421e-06
NIDDM1 [NCBI] 6.84421e-06
CMT4B2 [NCBI] 6.84421e-06
LWD [NCBI] 6.71531e-06
STAT3 [NCBI] 6.69746e-06
SMN2 [NCBI] 6.68201e-06
UMOD [NCBI] 6.68201e-06
NEUROD1 [NCBI] 6.51958e-06
LRP6 [NCBI] 6.51958e-06
PRND [NCBI] 6.51958e-06
SMAD7 [NCBI] 6.51958e-06
NPPB [NCBI] 6.51958e-06
TRAF1 [NCBI] 6.51958e-06
thrombocytopenic purpura, autoimmune [NCBI] 6.44304e-06
TG [NCBI] 6.30211e-06
FOLH1 [NCBI] 6.27576e-06
SCS [NCBI] 6.2551e-06
ALGS1 [NCBI] 6.2551e-06
SEDC [NCBI] 6.19577e-06
IGAN1 [NCBI] 6.11196e-06
BRIP1 [NCBI] 6.05828e-06
SLC7A9 [NCBI] 6.05828e-06
SOAT1 [NCBI] 6.05828e-06
MEIS1 [NCBI] 6.05828e-06
PON2 [NCBI] 6.05828e-06
HSCR1 [NCBI] 5.90994e-06
CYP17A1 [NCBI] 5.8953e-06
LCT [NCBI] 5.81742e-06
NIDDM [NCBI] 5.80529e-06
DM2 [NCBI] 5.80503e-06
spermatogenic failure, nonobstructive, y-linked [NCBI] 5.80503e-06
EDMD [NCBI] 5.80503e-06
RB1 [NCBI] 5.71947e-06
C4A [NCBI] 5.71403e-06
KRT18 [NCBI] 5.64222e-06
F13B [NCBI] 5.64222e-06
WWOX [NCBI] 5.64222e-06
SULT1A1 [NCBI] 5.64222e-06
KRT8 [NCBI] 5.64222e-06
XBP1 [NCBI] 5.64222e-06
CD209 [NCBI] 5.64222e-06
NDRG1 [NCBI] 5.64222e-06
AT [NCBI] 5.63835e-06
PARK1 [NCBI] 5.51853e-06
severe cutaneous adverse reaction, susceptibility to [NCBI] 5.51853e-06
CMT4D [NCBI] 5.51853e-06
alzheimer disease, susceptibility to, mitochondrial [NCBI] 5.51853e-06
NYS1 [NCBI] 5.51853e-06
muenke syndrome [NCBI] 5.51853e-06
CMT4C [NCBI] 5.51853e-06
pulmonary edema of mountaineers [NCBI] 5.51853e-06
lung cancer [NCBI] 5.46406e-06
hepatocellular carcinoma [NCBI] 5.46406e-06
leber optic atrophy [NCBI] 5.38695e-06
CHH [NCBI] 5.36267e-06
GARS [NCBI] 5.26443e-06
GDF15 [NCBI] 5.26443e-06
SFTPA1 [NCBI] 5.26443e-06
CYP3A5 [NCBI] 5.26443e-06
CALCR [NCBI] 5.26443e-06
NQO1 [NCBI] 5.26443e-06
FCGR2A [NCBI] 5.26443e-06
CBP2 [NCBI] 5.26443e-06
PDE4D [NCBI] 5.26443e-06
HAE [NCBI] 4.93721e-06
CLEC4M [NCBI] 4.91941e-06
DCTN1 [NCBI] 4.91941e-06
NOTCH3 [NCBI] 4.91941e-06
SLC5A1 [NCBI] 4.91941e-06
PRX [NCBI] 4.91941e-06
APOC3 [NCBI] 4.91941e-06
MTMR2 [NCBI] 4.91941e-06
COMP [NCBI] 4.8523e-06
FAAH [NCBI] 4.8e-06
TBX21 [NCBI] 4.6028e-06
IGFBP3 [NCBI] 4.6028e-06
DRD5 [NCBI] 4.6028e-06
GDAP1 [NCBI] 4.6028e-06
PFC [NCBI] 4.6028e-06
PLAU [NCBI] 4.6028e-06
ALK [NCBI] 4.59211e-06
F13A1 [NCBI] 4.59037e-06
CFB [NCBI] 4.59037e-06
FH [NCBI] 4.59037e-06
CSF3 [NCBI] 4.59037e-06
GC [NCBI] 4.53136e-06
WSS [NCBI] 4.41672e-06
ATS [NCBI] 4.41672e-06
cirrhosis, familial [NCBI] 4.41672e-06
coloboma, ocular [NCBI] 4.41672e-06
OCD1 [NCBI] 4.41672e-06
PGF [NCBI] 4.31102e-06
NFKBIA [NCBI] 4.31102e-06
PRKCA [NCBI] 4.31102e-06
ADRB1 [NCBI] 4.31102e-06
IRF6 [NCBI] 4.31102e-06
THBD [NCBI] 4.31102e-06
FLG [NCBI] 4.31102e-06
SELE [NCBI] 4.31102e-06
CYP2C9 [NCBI] 4.31102e-06
SCARB1 [NCBI] 4.31102e-06
CEBPA [NCBI] 4.31102e-06
ALOX5 [NCBI] 4.31102e-06
CYBA [NCBI] 4.31102e-06
NCF1 [NCBI] 4.31102e-06
SLC19A1 [NCBI] 4.31102e-06
thyroid carcinoma, papillary [NCBI] 4.24039e-06
LMNA [NCBI] 4.1974e-06
neural tube defects [NCBI] 4.18861e-06
SST [NCBI] 4.18308e-06
MSH2 [NCBI] 4.17603e-06
CMH [NCBI] 4.13358e-06
LKS [NCBI] 4.11603e-06
IDE [NCBI] 4.10439e-06
NFKB1 [NCBI] 4.0457e-06
GABRG2 [NCBI] 4.04116e-06
MEF2A [NCBI] 4.04116e-06
SLC7A5 [NCBI] 4.04116e-06
RNASEL [NCBI] 4.04116e-06
IL7R [NCBI] 4.04116e-06
GNB3 [NCBI] 4.04116e-06
RAD51 [NCBI] 4.04116e-06
RNASE3 [NCBI] 3.88734e-06
C5 [NCBI] 3.79078e-06
IL6R [NCBI] 3.79078e-06
VCAM1 [NCBI] 3.79078e-06
LTF [NCBI] 3.79078e-06
ANGPT2 [NCBI] 3.79078e-06
glycogen storage disease ii [NCBI] 3.66876e-06
IGF1 [NCBI] 3.5598e-06
MMP9 [NCBI] 3.5598e-06
NR4A2 [NCBI] 3.55781e-06
MUTYH [NCBI] 3.55781e-06
RETN [NCBI] 3.55781e-06
KCNJ2 [NCBI] 3.55781e-06
HMOX1 [NCBI] 3.55781e-06
CDK4 [NCBI] 3.53922e-06
amyloidosis, primary cutaneous [NCBI] 3.49789e-06
CMT4A [NCBI] 3.49789e-06
IHPS1 [NCBI] 3.49789e-06
DA2B [NCBI] 3.49789e-06
MTC [NCBI] 3.49789e-06
carnitine palmitoyltransferase ii deficiency, late-onset [NCBI] 3.49789e-06
HRAS [NCBI] 3.4466e-06
aHUS [NCBI] 3.34634e-06
hla-d histocompatibility type [NCBI] 3.34473e-06
CSF1 [NCBI] 3.34053e-06
PHB [NCBI] 3.34053e-06
C9 [NCBI] 3.34053e-06
IFNA1 [NCBI] 3.33867e-06
LCN2 [NCBI] 3.22939e-06
ALS1 [NCBI] 3.15107e-06
EPHB2 [NCBI] 3.13742e-06
CTSD [NCBI] 3.13742e-06
FLT3 [NCBI] 3.13742e-06
DRD3 [NCBI] 3.13742e-06
FLT1 [NCBI] 3.13742e-06
NRCLP1 [NCBI] 3.13398e-06
klippel-trenaunay-weber syndrome [NCBI] 3.11296e-06
obesity [NCBI] 3.03248e-06
down syndrome [NCBI] 3.03248e-06
nijmegen breakage syndrome [NCBI] 2.98253e-06
GHSR [NCBI] 2.94721e-06
IL1RN [NCBI] 2.94721e-06
GHRHR [NCBI] 2.94721e-06
SELP [NCBI] 2.94721e-06
HLA-DQB1 [NCBI] 2.94721e-06
ASIP [NCBI] 2.94721e-06
GATA4 [NCBI] 2.94721e-06
TGFB1 [NCBI] 2.92516e-06
CD36 [NCBI] 2.92516e-06
hemophilia a [NCBI] 2.92441e-06
GCCR [NCBI] 2.82916e-06
UBE3A [NCBI] 2.76876e-06
NR3C2 [NCBI] 2.76876e-06
CYP1B1 [NCBI] 2.76876e-06
LTC4S [NCBI] 2.76876e-06
thiopurine s-methyltransferase deficiency [NCBI] 2.73143e-06
SHEP1 [NCBI] 2.73143e-06
wolff-parkinson-white syndrome [NCBI] 2.73143e-06
argininosuccinic aciduria [NCBI] 2.73143e-06
parkinson disease, mitochondrial [NCBI] 2.73143e-06
sacral defect with anterior meningocele [NCBI] 2.73143e-06
PXE [NCBI] 2.72195e-06
HHF2 [NCBI] 2.68479e-06
OSM [NCBI] 2.6627e-06
NF1 [NCBI] 2.64841e-06
vitamin d-dependent rickets, type ii [NCBI] 2.63378e-06
OPA1 [NCBI] 2.63378e-06
MDLS [NCBI] 2.63378e-06
WFS1 [NCBI] 2.63378e-06
FGFR2 [NCBI] 2.60692e-06
EMD [NCBI] 2.60111e-06
MSX1 [NCBI] 2.60111e-06
COL4A1 [NCBI] 2.60111e-06
MYO5A [NCBI] 2.44338e-06
MMP1 [NCBI] 2.44338e-06
EGR2 [NCBI] 2.44338e-06
SLC12A3 [NCBI] 2.44338e-06
GSK3B [NCBI] 2.44338e-06
SLC3A1 [NCBI] 2.44338e-06
MC4R [NCBI] 2.38636e-06
SJS1 [NCBI] 2.30095e-06
OCA2 [NCBI] 2.30095e-06
CLL [NCBI] 2.30095e-06
porphyria variegata [NCBI] 2.29867e-06
BMP15 [NCBI] 2.29481e-06
FCHL [NCBI] 2.27067e-06
CDKN2A [NCBI] 2.24982e-06
DFSP [NCBI] 2.2237e-06
VUR1 [NCBI] 2.19765e-06
FGF2 [NCBI] 2.17188e-06
SLC22A5 [NCBI] 2.15472e-06
ALDH1A1 [NCBI] 2.15472e-06
AHSG [NCBI] 2.15472e-06
OPA1 [NCBI] 2.15472e-06
PPARGC1A [NCBI] 2.15472e-06
IL4R [NCBI] 2.15472e-06
SFRP1 [NCBI] 2.15472e-06
VASP [NCBI] 2.12966e-06
JME [NCBI] 2.09382e-06
mucopolysaccharidosis type iiic [NCBI] 2.09382e-06
BHD [NCBI] 2.09382e-06
sitosterolemia [NCBI] 2.09382e-06
SCZD9 [NCBI] 2.09382e-06
tetralogy of fallot [NCBI] 2.09382e-06
HMN5 [NCBI] 2.09382e-06
HSCR2 [NCBI] 2.09382e-06
KL [NCBI] 2.0225e-06
PTCH1 [NCBI] 2.0225e-06
CML [NCBI] 1.98497e-06
EVA [NCBI] 1.98497e-06
CVS [NCBI] 1.90309e-06
TNFRSF10A [NCBI] 1.89762e-06
IPF1 [NCBI] 1.89762e-06
CALCA [NCBI] 1.89762e-06
TCRB [NCBI] 1.89762e-06
HLA-DQA1 [NCBI] 1.89762e-06
SDC2 [NCBI] 1.8274e-06
INSR [NCBI] 1.81418e-06
TYMS [NCBI] 1.79812e-06
PROS1 [NCBI] 1.77958e-06
NOS2A [NCBI] 1.77958e-06
UCP1 [NCBI] 1.76121e-06
G6PD [NCBI] 1.73801e-06
costello syndrome [NCBI] 1.68687e-06
SPG3A [NCBI] 1.68687e-06
RBP4 [NCBI] 1.66794e-06
KCNJ11 [NCBI] 1.66794e-06
CYP11B2 [NCBI] 1.66794e-06
KDR [NCBI] 1.66704e-06
CTHM [NCBI] 1.56662e-06
leprosy, susceptibility to [NCBI] 1.56662e-06
SCZD4 [NCBI] 1.56662e-06
complement factor h deficiency [NCBI] 1.56662e-06
HPE3 [NCBI] 1.56662e-06
CDKN1B [NCBI] 1.56231e-06
MEFV [NCBI] 1.56231e-06
ENPP1 [NCBI] 1.4623e-06
MAOB [NCBI] 1.4623e-06
IL8 [NCBI] 1.4623e-06
RECQL3 [NCBI] 1.4623e-06
TNC [NCBI] 1.41528e-06
DNMT3B [NCBI] 1.36761e-06
CFI [NCBI] 1.36761e-06
SLC6A4 [NCBI] 1.35543e-06
PNPLA6 [NCBI] 1.34176e-06
phenylketonuria [NCBI] 1.31343e-06
RET [NCBI] 1.30549e-06
PPOX [NCBI] 1.27791e-06
complement component 2 deficiency [NCBI] 1.27791e-06
NBS1 [NCBI] 1.27791e-06
PF4 [NCBI] 1.27249e-06
LDLR [NCBI] 1.25034e-06
PSORS1 [NCBI] 1.21926e-06
BTK [NCBI] 1.20918e-06
PIGA [NCBI] 1.19294e-06
ICAM1 [NCBI] 1.19294e-06
IL13 [NCBI] 1.19294e-06
DAP [NCBI] 1.19294e-06
CXCR4 [NCBI] 1.19294e-06
LBP [NCBI] 1.15944e-06
FED [NCBI] 1.13505e-06
von willebrand disease [NCBI] 1.12915e-06
MDM2 [NCBI] 1.11244e-06
coproporphyria [NCBI] 1.11244e-06
CTCF [NCBI] 1.11244e-06
SMN1 [NCBI] 1.11111e-06
BWS [NCBI] 1.09103e-06
ACADS [NCBI] 1.03617e-06
ESR2 [NCBI] 1.03617e-06
MTCO1 [NCBI] 1.03617e-06
MAPT [NCBI] 1.02757e-06
scleroderma, familial progressive [NCBI] 1.02643e-06
malaria, susceptibility to [NCBI] 1.0264e-06
antithrombin iii deficiency [NCBI] 1.01854e-06
PEMT [NCBI] 9.63922e-07
RUNX2 [NCBI] 9.63922e-07
ABO [NCBI] 9.63922e-07
PKD1 [NCBI] 9.29333e-07
LQT1 [NCBI] 9.14188e-07
RP3 [NCBI] 9.11566e-07
LSA [NCBI] 9.11566e-07
JAK2 [NCBI] 9.03159e-07
ADHD [NCBI] 9.02553e-07
NPM1 [NCBI] 8.97362e-07
TLR9 [NCBI] 8.34615e-07
STK11 [NCBI] 8.30678e-07
SNRPN [NCBI] 8.30678e-07
FY [NCBI] 8.30678e-07
CASR [NCBI] 8.19878e-07
PI [NCBI] 8.11156e-07
PAM [NCBI] 8.03853e-07
VEGF [NCBI] 8.00939e-07
periodontitis, aggressive, 1 [NCBI] 7.87153e-07
neuropathy, congenital hypomyelinating [NCBI] 7.87153e-07
VHL [NCBI] 7.74587e-07
COL1A1 [NCBI] 7.73509e-07
GAA [NCBI] 7.69326e-07
CTLA4 [NCBI] 7.11271e-07
ABCA4 [NCBI] 7.11271e-07
HLA-DRA [NCBI] 7.11271e-07
apert syndrome [NCBI] 6.97303e-07
leiomyomatosis and renal cell cancer, hereditary [NCBI] 6.97303e-07
mycobacterium tuberculosis, susceptibility to [NCBI] 6.97303e-07
ATRX [NCBI] 6.97303e-07
PLG [NCBI] 6.57629e-07
MAOA [NCBI] 6.56444e-07
BRAF [NCBI] 6.5636e-07
AMACR [NCBI] 6.5636e-07
GLC1A [NCBI] 6.09288e-07
GNAS [NCBI] 5.98234e-07
DAZ [NCBI] 5.55427e-07
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 5.33338e-07
AOS [NCBI] 5.24666e-07
SI [NCBI] 5.204e-07
PIGR [NCBI] 5.204e-07
properdin deficiency, x-linked [NCBI] 5.1306e-07
MTATP6 [NCBI] 5.0915e-07
PPSH [NCBI] 5.07741e-07
SPDA1 [NCBI] 5.07741e-07
CEACAM5 [NCBI] 5.05931e-07
apc gene [NCBI] 5.04301e-07
TPO [NCBI] 4.83184e-07
GTS [NCBI] 4.76182e-07
ABCA1 [NCBI] 4.65512e-07
ERBB2 [NCBI] 4.65512e-07
APCS [NCBI] 4.65512e-07
IFNG [NCBI] 4.65512e-07
TNFRSF6 [NCBI] 4.65512e-07
melanoma, uveal [NCBI] 4.45532e-07
BCHE [NCBI] 4.36581e-07
KRT20 [NCBI] 3.96781e-07
MLL [NCBI] 3.85725e-07
FBN1 [NCBI] 3.7496e-07
factor vii deficiency [NCBI] 3.4938e-07
FHM1 [NCBI] 3.4471e-07
PTGS2 [NCBI] 3.29074e-07
PLAUR [NCBI] 3.28642e-07
DSG3 [NCBI] 3.15279e-07
ABCB11 [NCBI] 3.07646e-07
GEFS+ [NCBI] 3.04559e-07
pancreatic carcinoma [NCBI] 3.04559e-07
CBAVD [NCBI] 3.04559e-07
LEPR [NCBI] 2.86807e-07
CP [NCBI] 2.84334e-07
MTND1 [NCBI] 2.83337e-07
B2M [NCBI] 2.53475e-07
APP [NCBI] 2.27376e-07
CCM [NCBI] 2.13377e-07
OCP [NCBI] 2.13377e-07
EPO [NCBI] 2.1308e-07
HNFJ [NCBI] 2.10252e-07
ABCG2 [NCBI] 2.00403e-07
TPMT [NCBI] 1.93634e-07
C3 [NCBI] 1.7563e-07
PPARA [NCBI] 1.6766e-07
mucopolysaccharidosis type ii [NCBI] 1.58487e-07
mucopolysaccharidosis type iiib [NCBI] 1.54738e-07
autonomic control, congenital failure of [NCBI] 1.54738e-07
KTCN1 [NCBI] 1.54738e-07
GBA [NCBI] 1.42824e-07
NF2 [NCBI] 1.34478e-07
AKR1B1 [NCBI] 1.33644e-07
SLC2A2 [NCBI] 1.32846e-07
RPGR [NCBI] 1.32846e-07
HBD [NCBI] 1.14006e-07
UCP3 [NCBI] 1.13648e-07
lynch syndrome i [NCBI] 1.09528e-07
thiourea tasting [NCBI] 1.06653e-07
PDB [NCBI] 1.06653e-07
FDH [NCBI] 1.06653e-07
ABP1 [NCBI] 9.83591e-08
ATF3 [NCBI] 9.67907e-08
SLC11A1 [NCBI] 9.67907e-08
VHL [NCBI] 8.74454e-08
MTND4 [NCBI] 8.11495e-08
ACADM [NCBI] 7.17666e-08
GHR [NCBI] 7.08919e-08
NF2 [NCBI] 6.7032e-08
AMH [NCBI] 6.45137e-08
alopecia, androgenetic [NCBI] 6.30939e-08
ETM1 [NCBI] 5.77225e-08
mismatch repair cancer syndrome [NCBI] 5.77225e-08
JPS [NCBI] 5.4847e-08
SLPI [NCBI] 4.97718e-08
MCP [NCBI] 4.91114e-08
BSG [NCBI] 4.45183e-08
UGT1A1 [NCBI] 4.31798e-08
TERT [NCBI] 4.24598e-08
polycystic kidneys [NCBI] 3.73766e-08
LIP [NCBI] 3.64855e-08
CMM2 [NCBI] 3.64855e-08
glycogen storage disease v [NCBI] 3.64855e-08
HRG [NCBI] 3.58715e-08
BCL2 [NCBI] 3.33563e-08
EIF4E [NCBI] 3.33563e-08
ELN [NCBI] 3.33563e-08
CD [NCBI] 3.01696e-08
SNCA [NCBI] 2.80992e-08
LIPC [NCBI] 2.48787e-08
PTEN [NCBI] 1.62097e-08
BMP2 [NCBI] 1.52654e-08
UGB [NCBI] 1.52654e-08
PARP1 [NCBI] 1.02495e-08
CNC1 [NCBI] 8.47816e-09
APOD [NCBI] 7.13403e-09
TFF3 [NCBI] 7.13403e-09
MLH1 [NCBI] 6.19957e-09
SPP1 [NCBI] 5.63038e-09
ABCB1 [NCBI] 3.98296e-09
PAX3 [NCBI] 3.66095e-09
PAX6 [NCBI] 3.14061e-09
PSNP1 [NCBI] 2.65872e-09
HMBS [NCBI] 2.19811e-09
IL3 [NCBI] 1.09871e-09
BGLAP [NCBI] 2.02064e-10
H6PD [NCBI] 1.75682e-10
TSC2 [NCBI] 1.75682e-10
FSHR [NCBI] 1.01001e-10
VCP [NCBI] 1.01001e-10
FMR1 [NCBI] 8.95888e-11
asthma, susceptibility to [NCBI] 5.20697e-11
KCNH2 [NCBI] 1.59497e-11
CYP1A1 [NCBI] 5.44519e-14



Database Center for Life Science